25 August 2020 - Agenda items are revised with no indication of what has been changed.

The Department of Health published six versions of the agenda for the July 2020 PBAC meeting.

The first four agendas noted that Accord Healthcare sought a PBS listing for topotecan hydrochloride solution concentrate for three diseases:

• Small cell lung cancer
• Cervical cancer
• Ovarian cancer

The sixth and seemingly final version states that Accord Healthcare only sought a listing for ovarian cancer. It has been assumed that the requests for list topotecan hydrochloride solution concentrate for small cell lung cancer and cervical cancer have been withdrawn.